Scope
The attached source set (RACGP Red Book, National Guide) was audited for multimorbidity prioritisation deprescribing and care coordination. It does not provide complete claim-level coverage for that pathway. This page therefore records the evidence boundary only and must not be treated as a clinical protocol or as evidence of medicine registration, subsidy or local service eligibility.
The Bottom Line
- No Australian diagnostic, treatment, medicine, monitoring, referral or subsidy recommendation for Multimorbidity: clinical assessment & management is made on this page.
- The attached source set is limited to RACGP Red Book, National Guide; its presence does not extend any source beyond its stated population, purpose or jurisdiction.
- No threshold, dose, contraindication, test sequence, treatment order or referral timeframe should be inferred from this source-status record.
- Use an exact current condition-specific source and the applicable state, territory, specialist-service and formulary pathway before making a clinical decision.
How to find an applicable pathway
1
For a clinical decision, retrieve an exact current Australian primary source whose published scope covers the condition, population and decision being made.
2
Confirm the source version, publication status, population, setting and jurisdiction at the point of use, then document the exact pathway applied.
3
Keep regulatory approval, PBS subsidy, local formulary approval and service eligibility as separate checks; one does not establish the others.
4
If no exact source covers the decision, seek appropriate senior or specialist advice rather than filling the gap from an overseas pathway or from this page.
Safety limitation
- This page does not define condition-specific red flags, emergency tests or acute treatment for Multimorbidity: clinical assessment & management.
- If a person is acutely unwell, deteriorating or at immediate risk, use the current local emergency or retrieval pathway and condition-specific senior advice.
Implementation boundary
Source availability, referral pathways, public-health directions, medicine access and funded services vary by state, territory and health service.
Clinical use boundary
This independently written summary is not an official guideline. Check the linked source version, current TGA-approved product information where medicines are involved, and the applicable state, territory and local pathway at the point of care.
Source documents
Use the linked source documents for complete recommendations, evidence grading, exclusions and implementation detail.
- Royal Australian College of General PractitionersGuidelines for preventive activities in general practice10th edition, 2024; page updates checked 2026-08-20 路 accessed 2026-08-20view source
- National Aboriginal Community Controlled Health Organisation and Royal Australian College of General PractitionersNational guide to a preventive health assessment for Aboriginal and Torres Strait Islander people4th edition, 2024 路 accessed 2026-08-20view source
continue the learning
From guidance to deliberate practice and evidence
Choose what happens next. iatroX can carry this page's jurisdiction, source-check date and released version into an editable learning record, support your reflection, or let you browse the regional question bank while keeping this topic visible. No action records completion, starts a session or awards CPD/CME credit automatically.
Add this guidance review to CPD/CMEOpen an editable learning-log record with this page鈥檚 provenance attached. You confirm the activity, time, reflection and mappings.Reflect on this with TutorUse optional prompts to consider what you learned and what鈥攊f anything鈥攜ou may change. Suggestions are never inserted automatically.Browse the Australia question bankKeep this guidance topic in view, then choose your exam and filters. No session starts automatically.
Found a source update or regional discrepancy? Tell the iatroX editorial team.